Stockreport

Annovis Bio to Hold Investor Webinar and Q&A Session with CEO on April 14

Annovis Bio, Inc.  (ANVS) 
PDF BERWYN, Pa., April 13, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinso [Read more]